Dorflex, Sanofi's Consumer Healthcare brand, once again delivers a science-based solution so that Brazilians can move forward without worrying about pain. This is the new Dorflex MAX , with an exclusive formula with twice as much muscle relaxant and analgesic in a single tablet*, indicated to combat intense body pain, which can impact people on a daily basis.
To add innovation to the solution, it took more than 5 years of research by the Scientific Affairs unit, which reinforces the commitment to health and consumer needs, present at the center of decisions. The motto "Go ahead and leave the pain with us" continues with the mission of encouraging Brazilians, who struggle daily, about the importance of balance between pursuing goals and self-care.
Marília Zanoli
Consumer Healthcare Marketing Director at Sanofi
"Dorflex MAX highlights the commitment of our consumer unit to innovate and bring self-care - which is our great cause of agreement. And this only reinforces the power of the brand, 100% Brazilian and present in Brazilian homes for over 50 years. Dorflex is in the BrandZ ranking of the 50 most valuable Brazilian brands".
Stories inspired by real Brazilians
The launch continues the "Real Stories" campaign, which is currently on air, illustrated by Brazilians who, through creativity and determination, spare no effort to carry out their day-to-day activities. With this, the brand reinforces its positioning (Go ahead and leave the pain to us), being the care option in cases of pain. The campaign films are directed by Leandro HBL, from Bando Studio, and the audio production is by Fuzzr.
Silvio Silva
Commercial Director of Consumer Healthcare at Sanofi
" It is an enormous pride and satisfaction for the entire Dorflex team to bring yet another new product that delivers innovation and science to consumers. This result comes from an effort from many areas involved with the purpose of ensuring a pain-free and convenient routine for our audience, more a delivery for our consumers who are at the center of decision-making, in addition to the partnership we have with our customers to achieve this".
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!